F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on medical record review, staff and resident interviews, and policy review, the facility failed to ensure
medications were administered as ordered. This affected one (#134) out of the three residents reviewed for
medications. The facility census was 129.
Findings included:
Review of the medical record for Resident #134 revealed an admission date of 03/16/22 with medical
diagnoses of hypothyroidism, end stage renal disease, dependence on dialysis, chronic obstructive
pulmonary disease (COPD), and diabetes mellitus.
Review of the medical record for Resident #134 revealed a quarterly Minimum Data Set (MDS)
assessment, dated 08/17/23 which indicated Resident #134 was cognitively intact. The MDS indicated
Resident #134 required limited staff assistance with bed mobility and extensive staff assistance with
transfers, toileting, dressing, and bathing.
Review of the medical record for Resident #134 revealed a physician order, dated 08/16/23, for
ipratropium-albuterol inhalation aerosol 20-100 microgram (mcg) per actuation (act), one inhalation by
mouth three times per day on Monday, Wednesday, and Fridays for COPD.
Review of the medical record for Resident #134 revealed a Medication Administration Record (MAR) for
October 2023 which did not contain documentation to support Resident #134 received ipratropium-albuterol
inhalation aerosol as ordered on 10/02/23, 10/04/23, 10/09/23, 10/11/23, 10/13/23, 10/16/23, 10/18/23,
10/23/23, and 10/27/23. Review of the MAR for November 2023 revealed no documentation to support
Resident #134 received ipratropium-albuterol inhalation aerosol as ordered on 11/03/23, 11/06/23,
11/08/23, 11/13/23, 11/15/23, 11/17/23, and 11/20/23.
Interview on 11/20/23 at 11:05 A.M. with Resident #134 confirmed the nursing staff administer her
medications and that she had not received her ipratropium-albuterol inhalation medication as ordered.
Resident #134 stated she was told by the nursing staff that the medication had not been delivered by the
pharmacy. Resident #134 denied any medical concerns related to not receiving the ipratropium-albuterol
inhalation medication as ordered.
Interview on 11/20/23 at 3:00 P.M. with Director of Nursing (DON) confirmed Resident #134 had the
ipratropium-albuterol aerosols ordered Monday, Wednesday and Friday routinely and an as needed
medication for use other days/times. The DON confirmed Resident #134 did not receive the
ipratropium-albuterol aerosol as ordered on 11/03/23, 11/06/23, 11/08/23, 11/13/23, 11/15/23, 11/17/23,
and 11/20/23. DON stated the pharmacy changed the medication from an inhaler administration to
nebulizer
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
366388
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366388
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/21/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Stonespring of Vandalia
4000 Singing Hills Bvld
Dayton, OH 45414
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
administration and some of the nursing staff were not aware of the change. DON confirmed nursing staff
documented the ipratropium-albuterol aerosol as not available from pharmacy as the reason the medication
was not given. DON was not able to determine the date in which the pharmacy changed to administration of
the medication from an inhaler to via nebulizer.
Interview on 11/21/23 at 1:04 P.M. with DON confirmed Resident #134 did not receive the
ipratropium-albuterol aerosol as ordered on 10/02/23, 10/04/23, 10/09/23, 10/11/23, 10/13/23, 10/16/23,
10/18/23, 10/23/23, and 10/24/23.
Review of the policy titled, Administration Oral Medications, revised June 2015, stated the facility wound
ensure patients are given medication per the physician orders.
This deficiency represents non-compliance investigated under Complaint Number OH00147589.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366388
If continuation sheet
Page 2 of 2